Column Group LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZNW)

Column Group LLC acquired a new stake in shares of Surrozen, Inc. (NASDAQ:SRZNW) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 810,088 shares of the company’s stock, valued at approximately $8,870,000. Surrozen comprises about 12.4% of Column Group LLC’s portfolio, making the stock its 3rd largest holding.

Surrozen Stock Performance

NASDAQ SRZNW opened at $0.02 on Friday. The firm’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.02. Surrozen, Inc. has a twelve month low of $0.01 and a twelve month high of $0.11.

About Surrozen

Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.